Adaptin Bio (APTN) Return on Capital Employed (2024 - 2026)
Adaptin Bio (APTN) posted Return on Capital Employed of 313.83% for Q1 2026, down 24.12% sequentially from 413.59% in Q4 2025, and up 102634.0% YoY from N/an in Q1 2025.
Adaptin Bio (APTN) Return on Capital Employed (2024 - 2026) Analysis & Trends
Adaptin Bio has reported Return on Capital Employed for 3 years, with the latest figure at 313.83% in Q1 2026.
- Quarterly Return on Capital Employed rose 102634.0% year-over-year to 313.83% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 313.83% (up 102634.0% YoY) and the FY2025 annual result came in at 322.46%, up 26156.0% from the prior year.
- Return on Capital Employed slipped to 313.83% in Q1 2026 per APTN's latest filing, from 413.59% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 890.69% in Q3 2024 and troughed at 712.52% in Q1 2025.
- A 3-year average of 250.64% and a median of 363.71% in 2025 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed sank 91843 bps in 2025, then soared 102634 bps in 2026.
- Over 3 years, Return on Capital Employed stood at 60.9% in 2024, then soared by 579 bps to 413.59% in 2025, then slipped by 24 bps to 313.83% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 313.83%, 413.59%, and 844.31% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 298.85% |
| Mar 31, 2026 | 313.83% |
| Dec 31, 2025 | 413.59% |
| Sep 30, 2025 | 844.31% |
| Jun 30, 2025 | -362.04% |
| Mar 31, 2025 | -712.52% |
| Dec 31, 2024 | 60.90% |
| Sep 30, 2024 | 890.69% |
| Jun 30, 2024 | 556.39% |